Valuation: Getinge AB

Market Cap 67.33B 6.7B 5.95B 5.57B 5.07B 9.55B 645B 9.68B 26.06B 329B 25.16B 24.61B 1,055B P/E 2026 *
21.3x
P/E 2027 * 19x
Enterprise Value 75.57B 7.52B 6.68B 6.25B 5.69B 10.72B 724B 10.86B 29.25B 369B 28.24B 27.62B 1,184B EV / Sales 2026 *
2.14x
EV / Sales 2027 * 1.96x
Free-Float
79.13%
Yield 2026 *
2.1%
Yield 2027 * 2.29%
1 day+11.16%
1 month+11.16%
3 months+24.69%
6 months+7.62%
Current year+13.12%
Current year 20.05
Extreme 20.05
25
1 year 20.05
Extreme 20.05
25
3 years 15.62
Extreme 15.62
25
5 years 15.62
Extreme 15.62
48.01
10 years 8.75
Extreme 8.75
48.01
Manager TitleAgeSince
Chief Executive Officer 54 2017-04-30
Director of Finance/CFO 48 2024-03-30
Compliance Officer 47 2020-09-30
Director TitleAgeSince
Chairman 65 2019-04-22
Chairman 75 -
Director/Board Member 70 2006-12-31
Change 5-day change 1-year change 3-year change Capi.($)
+11.16%-.--% - - 6.77B
-2.17%-4.33%-27.56%+1.00% 171B
+0.17%-2.34%-8.83%+11.15% 110B
-0.88%+1.19%-25.04%-0.32% 106B
-0.69%-3.57%-47.61%-12.45% 75.99B
+3.17%-0.03%-0.64%+72.98% 57.3B
-0.52%-0.65%-6.74%-30.92% 48.76B
+3.44%+7.90%+19.12%+59.15% 50.19B
-0.85%+0.85%-16.51%+20.14% 41.14B
-0.07%-1.42%+30.49%-8.80% 32.56B
Average +1.58%-1.46%-9.26%+12.44% 77B
Weighted average by Cap. +0.17%-2.07%-15.93%+9.54%

Financials

2026 *2027 *
Net sales 35.28B 3.51B 3.12B 2.92B 2.66B 5B 338B 5.07B 13.66B 172B 13.18B 12.9B 553B 37.33B 3.71B 3.3B 3.09B 2.81B 5.29B 358B 5.37B 14.45B 182B 13.95B 13.64B 585B
Net income 3.17B 316M 280M 262M 239M 450M 30.39B 456M 1.23B 15.48B 1.19B 1.16B 49.71B 3.56B 354M 315M 294M 268M 505M 34.11B 512M 1.38B 17.37B 1.33B 1.3B 55.8B
Net Debt 8.24B 820M 728M 681M 621M 1.17B 78.96B 1.18B 3.19B 40.22B 3.08B 3.01B 129B 6.01B 598M 531M 497M 453M 852M 57.6B 864M 2.33B 29.33B 2.25B 2.2B 94.22B
Logo Getinge AB
Getinge AB is a Sweden-based company operating within healthcare sector. The Company provides hospitals and Life Science institutions with products and solutions aimed at improving clinical outcomes and optimizing workflows. The Company’s reporting segments have the following activities: Acute Care Therapies develops solutions for life-sustaining care in acute health conditions. Life Science offers a comprehensive range of equipment, technical expertise and prevention consultation contamination in pharmaceutical production, biomedical research, production of medical equipment and in various laboratory applications. Surgical Workflows offers products and services for the effective disinfection and sterilization of instruments used in operations, operating tables and others hardware for operating rooms and advanced IT systems for efficient and secure workflows in hospitals.
Employees
11,758
Trader
Investor
Global
Quality
ESG MSCI
B
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
11
Last Close Price
248.00SEK
Average target price
251.70SEK
Spread / Average Target
+1.49%

Quarterly revenue - Rate of surprise